What are the latest precision diagnostics for advanced melanoma
According to the NCCN Guidelines for Melanoma (2023), the key molecular diagnostic tests for advanced melanoma include:
- BRAF Mutation Testing:
- Mandatory testing for all metastatic cases
- Tests for BRAF V600 mutations (most commonly V600E)
- Essential for determining eligibility for BRAF/MEK inhibitor therapy
- Next-Generation Sequencing (NGS): The American Society of Clinical Oncology (ASCO) guidelines recommend comprehensive genomic profiling that includes testing for:
- NRAS mutations
- KIT mutations
- Other potentially actionable mutations
- Tumor mutational burden (TMB)
- PD-L1 Testing: The National Cancer Institute (NCI) notes that while PD-L1 testing is available, it's not required before starting immunotherapy, as patients may respond regardless of PD-L1 status.
Additional Testing Recommendations: According to NCCN Guidelines:
- Molecular testing should be conducted on the most recent tissue sample when possible
- Testing should be performed in CLIA-certified laboratories
- Results should be available within 10 working days to guide treatment decisions
Always consult with your healthcare team about which tests are appropriate for your specific situation, as testing strategies may be individualized based on various clinical factors.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Melanoma — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Melanoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Melanoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Melanoma
- What questions should I ask my oncologist about locally advanced Melanoma
- What biomarker testing is recommended for locally advanced Melanoma
- What clinical trials are available for locally advanced Melanoma
- What is the standard of care for locally advanced Melanoma according to NCCN guidelines
- What factors does my oncologist consider when recommending a specific treatment regimen for my advanced melanoma?...
- What does progression mean for Melanoma and what happens next
- What should caregivers know about Melanoma treatment
- What is oligometastatic Melanoma and can it be cured